One-step, fast, 18F-19F isotopic exchange radiolabeling of difluoro-dioxaborinins and use of such compounds in treatment
AssigneesCornell University, Memorial Sloan Kettering Cancer Center
InventorsRichard Ting, Omer Aras, Feifei An, Nandi Chen
Life of this patent
Estimating the term…
Abstract
A compound according to Formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, wherein X1 and X2 are each independently 18F or 19F; R1 and R2 are each independently alkyl, amine, perfluoroalkyl, alkenyl, alkynyl, aryl, or aralkenyl; and R3 is H, halo, alkyl, alkyl ester, alkenyl, alkynyl, aryl, or aralkenyl; or wherein: R1 and R3 or R2 and R3 join to form a 6-membered cycloalkyl or heterocyclyl; or R1 and R3, R2 and R3, or R1, R2, and R3 join to form a substituted or unsubstituted polycyclic ring, wherein the polycyclic ring comprises fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl rings.
Claims18
A compound according to Formula (I)
- or a pharmaceutically acceptable salt and/or solvate thereof, wherein
- X1 and X2 are each independently 18F or 19F;
- and
- R1 and R3, R2 and R3, or R1, R2, and R3 join to form a substituted or unsubstituted polycyclic ring;
- wherein the compound of Formula (I) or a pharmaceutically acceptable salt and/or solvate thereof is tetracycline-BF2, glycylcycline-BF2, emodin-BF2, doxorubicin-BF2, or daunorubicin-BF2.
Dependencies are inferred from the claim text.